Fredag 27 December | 04:50:27 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-02-14 11:30 Bokslutskommuniké 2024
2024-12-10 - Extra Bolagsstämma 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning COMBI 0.00 SEK
2024-05-23 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning COMBI 0.00 SEK
2023-05-25 - Årsstämma
2023-05-12 - Kvartalsrapport 2023-Q1
2023-02-17 - Bokslutskommuniké 2022
2022-11-11 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning COMBI 0.00 SEK
2022-05-19 - Årsstämma
2022-05-12 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-06-07 - Split COMBI 20:1
2021-05-26 - X-dag ordinarie utdelning COMBI 0.00 SEK
2021-05-25 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-02-17 - Bokslutskommuniké 2020
2020-11-13 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-06-30 - X-dag ordinarie utdelning COMBI 0.00 SEK
2020-06-29 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2
2019-05-17 - Kvartalsrapport 2019-Q1
2019-05-16 - Årsstämma
2019-05-15 - X-dag ordinarie utdelning COMBI 0.00 SEK
2019-02-14 - Bokslutskommuniké 2018
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-04 - X-dag ordinarie utdelning COMBI 0.00 SEK
2018-05-03 - Årsstämma
2018-05-03 - Kvartalsrapport 2018-Q1
2018-01-29 - Bokslutskommuniké 2017
2017-11-01 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2
2017-05-18 - Kvartalsrapport 2017-Q1
2017-05-10 - X-dag ordinarie utdelning COMBI 0.00 SEK
2017-05-09 - Årsstämma
2017-01-31 - Bokslutskommuniké 2016
2017-01-26 - Extra Bolagsstämma 2017
2016-11-17 - Kvartalsrapport 2016-Q3
2016-08-17 - Kvartalsrapport 2016-Q2
2016-05-19 - Kvartalsrapport 2016-Q1
2016-04-05 - X-dag ordinarie utdelning COMBI 0.00 SEK
2016-04-04 - Årsstämma
2016-02-18 - Bokslutskommuniké 2015
2015-11-19 - Kvartalsrapport 2015-Q3
2015-08-20 - Kvartalsrapport 2015-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriBioteknik
CombiGenes vision är att ge patienter som drabbats av svåra sjukdomar möjlighet till ett bättre liv genom genterapi och andra former av avancerade behandlingar. Bolagets verksamhet har tre fokusområden: inlicensiering av nya tillgångar, utveckling av dessa tillgångar till proof-of-concept samt utlicensiering av tillgångarna till en strategisk partner för fortsatt utveckling och kommersialisering. CombiGene has sitt säte i Stockholm.
2024-11-14 15:40:00

The shareholders of CombiGene AB (publ) (“CombiGene” or the “Company”) have previously been given notice to attend the Extraordinary General Meeting on 10 December 2024 at 13.30 CET via digital connection. The following is supplemented with further information regarding the shareholder Strategic Partner A/S's proposal for election of Board members, deputy Board member and Chairman of the Board.

The shareholder Strategic Partner A/S proposes that Luca Di Stefano and Jakob Bendtsen be elected as new Board members, that Marcus Isaksson be re-elected as Board member and that Lars Thunberg be elected as new deputy Board member. Luca Di Stefano is proposed as Chairman of the Board. The proposal means that Jonas Ekblom, Gunilla Lundmark, Peter Nilsson, Per Lundin, and Malin Almgren are replaced as Board members.
 
Luca Di Stefano
Born: 1978
 
Luca holds a degree in Market Economy from Frans Schartau Business Institute and International Relations from Stockholm University. Luca is an investor, Board professional, and founder of several companies in media and IT. Since 2017, also held an active role as CEO/operational manager and Board member of several growth companies. Most recently, he was co-owner and CEO of the digital marketing agency Brandson AB, which was later acquired by Defiso Media AB.
 
Luca is Chairman of the Board and Board member of the listed companies Tellusgruppen AB, Refine Group AB and Upgrade Invest Nordic AB. He is also a Board member of several private investment/consulting companies such as XLNT group AB, Mresell Group AB and Hamax Holding AB. Luca is currently responsible for the Swedish investment company Molcap and oversees their unlisted portfolio. 
 
Luca does not hold any shares in CombiGene and is independent in relation to the Company and its senior management but not in relation to major shareholders.
 
Jakob Bendtsen
Born: 1978
 
Education and experience: Jakob holds and academic audit and accounting degree from Copenhagen Business School in Denmark. He has worked over 25 years in the audit, accounting, tax advisory and general consulting sector. Jakob has previously held senior financial and accounting roles in various companies in Denmark and US. He was previously a Board member of the Danish companies Rovsing A/S and Nordic Compound Invest A/S. 
 
Board director and CEO in the Danish company Strategic Partners A/S as well as CEO in Cewijo ApS.
 
Jakob does not hold any shares in CombiGene and is independent in relation to the Company and its senior management but not in relation to major shareholders.
 
Lars Thunberg
Born: 1966
 
Lars holds an academic degree in business administration from Lunds University. He has over 30 years of experience in finance and company development. He has worked for NGM Stock market as consultant to start ups. He also has working experience as business developer and as a Board professional. Lars was one of the founders of CombiGene. Lars also founded VA Automotive Groupe during the years 2008-2018 which was listed at Nasdaq First North Growth Market. Lars have international experience from working in Hong Kong, China and Europe.
 
Chairman of the Board and CEO of VA Components i Hässleholm AB, M & L Industriförvaltning AB, PR Development AB and Casator Care AB.
 
Lars hold through the closely related company M & L Industriförvaltning AB 650,000 shares in CombiGene. Lars is independent in relation to the Company, its senior management and major shareholders.